Clinical trial
Intensive Molecular and Electropathological Characterization of patientS undergOing atriaL fibrillATion ablatION: a Multicenter Prospective Cohort Study
NCT04342312 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intensive Molecular and Electropathological Characterization of patientS undergOing atriaL fibrillATion ablatION: a Multicenter Prospective Cohort Study
- Lead sponsor
- Maastricht University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 5, 2020
- Completion date
- May 1, 2024
- Enrollment
- 500 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, atrial fibrillation paroxysmal, atrial fibrillation, persistent